Clinical trial
A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee
NCT00483977 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00483977 |
|---|---|
| Title | A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee |
| Official title | A 2 Week, Randomized, Double Blind, Placebo And Positive Controlled, Parallel Group, Multicentre Study To Assess The Efficacy And Tolerability Of PF-00592379 In Patients With Moderate To Severe Pain Due To Osteoarthritis |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Oxycodone, Placebo, PF-000592379 |
| Enrollment | 113 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 8, 2007 |
| Last update posted | Apr 29, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: